Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Many women with hard-to-treat acne also have PCOS.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Non-obese women with hair loss have higher heart disease risk.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Internet and community fair recruitment effectively gathered a diverse group for a menstrual health survey.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.